|
"hsu c"的相關文件
顯示項目 726-735 / 881 (共89頁)
<< < 68 69 70 71 72 73 74 75 76 77 > >>
每頁顯示[10|25|50]項目
| 國立交通大學 |
2014-12-08T15:25:22Z |
Low frequency noise degradation in ultra-thin oxide (I5A) analog n-MOSFETs resulting from valence-band tunneling
|
Wu, JW; You, JW; Ma, HC; Cheng, CC; Hsu, C; Huang, GW; Chang, CS; Wang, T |
| 國立成功大學 |
2014-11 |
Phase I, dose-escalation study of the investigational drug D07001-F4, an oral formulation of gemcitabine HCl, in patients (pts) with advanced solid tumors or lymphoma
|
Lin, C.; Su, W.; Lee, J.; Hsu, C.; Cheng, A.; Lin, C.; Ho, H.; Huang, C.; Hsueh, S.; Yang, J |
| 國家衛生研究院 |
2014-08 |
Two new acidic diterpenoids from the heartwood of Pinus massoniana LAMB
|
Mohamed, HA;Hsieh, CL;Hsu, C;Kuo, CC;Chang, HS;Lee, CK;Lee, TH;Wu, JB;Chang, CI;Kuo, YH |
| 國家衛生研究院 |
2014-07 |
Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians
|
Chen, P;Takeuchi, F;Lee, JY;Li, H;Wu, JY;Liang, J;Long, J;Tabara, Y;Goodarzi, MO;Pereira, MA;Kim, YJ;Go, MJ;Stram, DO;Vithana, E;Khor, CC;Liu, J;Liao, J;Ye, X;Wang, Y;Lu, L;Young, TL;Lee, J;Thai, AC;Cheng, CY;van Dam, RM;Friedlander, Y;Heng, CK;Koh, WP;Chen, CH;Chang, LC;Pan, WH;Qi, Q;Isono, M;Zheng, W;Cai, Q;Gao, Y;Yamamoto, K;Ohnaka, K;Takayanagi, R;Kita, Y;Ueshima, H;Hsiung, CA;Cui, J;Sheu, WH;Rotter, JI;Chen, YD;Hsu, C;Okada, Y;Kubo, M;Takahashi, A;Tanaka, T;van Rooij, FJ;Ganesh, SK;Huang, J;Huang, T;Yuan, J;Hwang, JY;Gross, MD;Assimes, TL;Miki, T;Shu, XO;Qi, L;Chen, YT;Lin, X;Aung, T;Wong, TY;Teo, YY;Kim, BJ;Kato, N;Tai, ES |
| 國家衛生研究院 |
2014-07 |
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, YC;Li, CP;Yen, CJ;Hsu, C;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Yeh, KH;Cheng, AL |
| 國家衛生研究院 |
2014-06-20 |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo, SH;Yeh, KH;Chen, LT;Lin, CW;Hsu, PN;Hsu, C;Wu, MS;Tzeng, YS;Tsai, HJ;Wang, HP;Cheng, AL |
| 國家衛生研究院 |
2014-06 |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu, C;Tsou, HH;Lin, SJ;Wang, MC;Yao, M;Hwang, WL;Kao, WY;Chiu, CF;Lin, SF;Lin, J;Chang, CS;Tien, HF;Liu, TW;Chen, PJ;Cheng, AL |
| 國立成功大學 |
2014-06 |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo, S-H; Yeh, K-H; Chen, L-T; Lin, C-W; Hsu, P-N; Hsu, C.; Wu, M-S; Tzeng, Y-S; Tsai, H-J; Wang, H-P; Cheng, A-L |
| 國家衛生研究院 |
2014-04 |
Prevention of chemotherapy-induced hbv-related hepatitis flare in lymphoma patients with resolved hbv infection: Cost analysis
|
Tsou, HH;Yang, HC;Chuang, MH;Wu, HY;Hsu, YT;Chang, WJ;Hsiao, CF;Hsu, C;Grp, Taiwan Cooperative Oncology |
| 國家衛生研究院 |
2014-01-03 |
Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin
|
Ou, DL;Lee, BS;Lin, LI;Liou, JY;Liao, SC;Hsu, C;Cheng, AL |
顯示項目 726-735 / 881 (共89頁)
<< < 68 69 70 71 72 73 74 75 76 77 > >>
每頁顯示[10|25|50]項目
|
